The Patent Finder

Aurigene Oncology Limited

Also on record
Records under this name other than the patents Aurigene Oncology Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 46 patents it holds.

Back to Aurigene Oncology Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 12,428,379Acylsulfonamide KAT6A Inhibitors
In force
 · High confidence
In forceHigh confidence
US 10,077,259Bicyclic Heterocyclic Derivatives as Bromodomain Inhibitors
Lapsed on the fee record
Ended Sep 18, 2026 · High confidence
Lapsed on the fee recordEnded Sep 18, 2026High confidence
US 11,332,460Process for the Preparation of a Sulfonamide Structured Kinase Inhibitor
Lapsed on the fee record
Ended May 17, 2026 · High confidence
Lapsed on the fee recordEnded May 17, 2026High confidence
US 11,311,517Combination of Small Molecule CD-47 Inhibitors with Other Anti-Cancer Agents
Lapsed on the fee record
Ended Apr 26, 2026 · High confidence
Lapsed on the fee recordEnded Apr 26, 2026High confidence
US 11,186,576Pyrazolo[1,5-a][1,3,5]triazine and Pyrazolo[1,5-a]pyrimidine Derivatives as CDK Inhibitors
Lapsed on the fee record
Ended Nov 30, 2025 · High confidence
Lapsed on the fee recordEnded Nov 30, 2025High confidence
US 10,870,637Process for the Preparation of a Sulfonamide Structured Kinase Inhibitor
Lapsed on the fee record
Ended Dec 22, 2024 · High confidence
Lapsed on the fee recordEnded Dec 22, 2024High confidence
US 12,005,045Method of Modulating Tigit and PD-1 Signalling Pathways Using 1,2,4-Oxadiazole Compounds
Term ended
Term ended May 25, 2022 · High confidence
Term endedTerm ended May 25, 2022High confidence
14/478,7591,2,4-Oxadiazole Derivatives as Immunomodulators
Abandoned
Abandoned Oct 25, 2016
AbandonedAbandoned Oct 25, 2016
16/343,681Dual Inhibitors of Vista and PD-1 Pathways
Abandoned
Abandoned Apr 3, 2025
AbandonedAbandoned Apr 3, 2025
17/045,916Method of Modulating Tigit and PD-1 Signalling Pathways Using 1,2,4-Oxadiazole Compounds
Abandoned
Abandoned Jul 22, 2026
AbandonedAbandoned Jul 22, 2026
10 of 53 records shown.
Pro members see all 53.
Pro members: see all 53 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited